Trial NCT00954005

View at ClinicalTrials.gov 
Org. Study IDs: 001

Last trial update was posted on 2015-08-19

MeSH Interventions

Gemcitabine Oxaliplatin Rituximab

MeSH Conditions

Lymphoma

Other Conditions

Indolent Lymphoma

Stopping Reasons

Predefined termination criterion of > 10 patients without CR or PR was matched.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID